Amdocs Limited (NASDAQ:DOX – Get Free Report) announced a quarterly dividend on Wednesday, May 13th. Investors of record on Tuesday, June 30th will be given a dividend of 0.569 per share by the technology company on Friday, July 31st. This represents a c) dividend on an annualized basis and a dividend yield of 3.8%. The ex-dividend date is Tuesday, June 30th.
Amdocs has increased its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 14 years. Amdocs has a payout ratio of 29.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Amdocs to earn $7.22 per share next year, which means the company should continue to be able to cover its $2.27 annual dividend with an expected future payout ratio of 31.4%.
Amdocs Price Performance
NASDAQ:DOX opened at $59.93 on Thursday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The stock’s 50-day simple moving average is $65.54 and its 200 day simple moving average is $73.80. The company has a market cap of $6.47 billion, a P/E ratio of 11.59, a P/E/G ratio of 1.10 and a beta of 0.40. Amdocs has a 52-week low of $59.40 and a 52-week high of $95.41.
Key Amdocs News
Here are the key news stories impacting Amdocs this week:
- Positive Sentiment: Amdocs reported fiscal Q2 non-GAAP EPS of $1.78, slightly ahead of estimates, and revenue of $1.17 billion, which also topped expectations. The company also highlighted 3.9% year-over-year revenue growth, record Europe revenue, a $4.28 billion backlog, and continued share repurchases. Article Title
- Positive Sentiment: The company issued FY 2026 EPS guidance above consensus and reaffirmed a healthy free cash flow outlook, which supports the investment case and suggests continued profitability. Article Title
- Positive Sentiment: Amdocs announced a quarterly dividend of $0.569 per share, implying a 3.8% annualized yield, which may appeal to income-focused investors. Article Title
- Positive Sentiment: The company also announced several new customer wins and product milestones, including deals with Telefónica Móviles Argentina, Vodafone Ireland, Lumen Technologies, and Qué tal Móvil, plus a benchmark achievement for its Entitlement Server on Microsoft Azure, reinforcing demand for its telecom software. Article Title
- Neutral Sentiment: Amdocs said longtime CFO Tamar Rapaport-Dagim will retire, with internal successor Tal Rozenfeld taking over on June 1. The transition appears orderly, but investors may be waiting to see how the new CFO manages execution. Article Title
- Negative Sentiment: The stock’s recent weakness may also reflect broader market reaction to the earnings release, since the beat was small and operating margin declined year over year due to leadership-transition costs. Article Title
Amdocs Company Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
See Also
- Five stocks we like better than Amdocs
- Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar
- Oklo Stock Could Be Ready for Another Massive Run
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
